{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:14Z","timestamp":1707523934204},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,22]]},"DOI":"10.7759\/cureus.45802","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T05:59:31Z","timestamp":1695448771000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunoglobulin E (IgE)-Mediated Multiple Myeloma Presenting as Pleural Effusion"],"prefix":"10.7759","author":[{"given":"Sarah","family":"Nisar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anees","family":"Ur Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Safiullah","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.19.00025","article-title":"Epidemiology of hematologic malignancies in real-world settings: findings from the hemato-oncology Latin America observational registry study","volume":"5","author":"Tietsche de Moraes Hungria V","year":"2019","unstructured":"Tietsche de Moraes Hungria V, Chiattone C, Pavlovsky M, et al.. Epidemiology of hematologic malignancies in real-world settings: findings from the hemato-oncology Latin America observational registry study. J Glob Oncol. 2019, 5:1-19. 10.1200\/JGO.19.00025","journal-title":"J Glob Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar SV","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022, 97:1086-107. 10.1002\/ajh.26590","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan AJ","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, et al.. Diagnosis and management of multiple myeloma: a review. JAMA. 2022, 327:464-77. 10.1001\/jama.2022.0003","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1515\/almed-2021-0087","article-title":"IgE multiple myeloma: detection and follow-up","volume":"3","author":"Nafr\u00eda Jim\u00e9nez B","year":"2022","unstructured":"Nafr\u00eda Jim\u00e9nez B, Oliveros Conejero R. IgE multiple myeloma: detection and follow-up. Adv Lab Med. 2022, 3:79-90. 10.1515\/almed-2021-0087","journal-title":"Adv Lab Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005815","article-title":"IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells","volume":"10","author":"Kehl N","year":"2022","unstructured":"Kehl N, Kilian M, Michel J, et al.. IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells. J Immunother Cancer. 2022, 10:e005815. 10.1136\/jitc-2022-005815","journal-title":"J Immunother Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26045","article-title":"Myelomatous pleural effusion: a rare occurrence in multiple myeloma","volume":"14","author":"Amjad MA","year":"2022","unstructured":"Amjad MA, Hamid Z, Ramakrishna S, Frank R, Ochieng P. Myelomatous pleural effusion: a rare occurrence in multiple myeloma. Cureus. 2022, 14:e26045. 10.7759\/cureus.26045","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1684\/abc.2017.1263","article-title":"A new case of IgE multiple myeloma with review of literature","volume":"75","author":"Vignon G","year":"2017","unstructured":"Vignon G, Cogn\u00e9e AS, Carrere F, et al.. A new case of IgE multiple myeloma with review of literature. Ann Biol Clin (Paris). 2017, 75:442-4. 10.1684\/abc.2017.1263","journal-title":"Ann Biol Clin (Paris)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2017.09.015","article-title":"IgE monoclonal gammopathy: a case report and literature review","volume":"51","author":"Hejl C","year":"2018","unstructured":"Hejl C, Mestiri R, Carmoi T, Bugier S, Chianea D, Renard C, Vest P. IgE monoclonal gammopathy: a case report and literature review. Clin Biochem. 2018, 51:103-9. 10.1016\/j.clinbiochem.2017.09.015","journal-title":"Clin Biochem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/2047","article-title":"A case of bilateral pleural effusion as the first sign of multiple myeloma","volume":"18","author":"Xu XL","year":"2012","unstructured":"Xu XL, Shen YH, Shen Q, Zhou JY. A case of bilateral pleural effusion as the first sign of multiple myeloma. Eur J Med Res. 2012, 18:1186-2047. 10.1186\/2047","journal-title":"Eur J Med Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2015.327","article-title":"Pleural myelomatous involvement in multiple myeloma: five cases","volume":"35","author":"Ghorbel IB","year":"2015","unstructured":"Ghorbel IB, Feki NB, Lamloum M, et al.. Pleural myelomatous involvement in multiple myeloma: five cases. Ann Saudi Med. 2015, 35:327-30. 10.5144\/0256-4947.2015.327","journal-title":"Ann Saudi Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2401","article-title":"Pleural effusion and multiple myeloma - more than meets the eye: a case report","volume":"15","author":"Ramos AL","year":"2021","unstructured":"Ramos AL, Trindade M, Santos Pinto A, Brand\u00e3o JR, Pedrosa C, Pinto A. Pleural effusion and multiple myeloma - more than meets the eye: a case report. Mol Clin Oncol. 2021, 15:238. 10.3892\/mco.2021.2401","journal-title":"Mol Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25209","article-title":"Clinical characteristics and treatment outcomes in IgE multiple myeloma: a case-control study","volume":"93","author":"Jurczyszyn A","year":"2018","unstructured":"Jurczyszyn A, Castillo JJ, Vesole DH, et al.. Clinical characteristics and treatment outcomes in IgE multiple myeloma: a case-control study. Am J Hematol. 2018, 93:E238-41. 10.1002\/ajh.25209","journal-title":"Am J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70187-X","article-title":"Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial","volume":"11","author":"Mateos MV","year":"2010","unstructured":"Mateos MV, Oriol A, Mart\u00ednez-L\u00f3pez J, et al.. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial. Lancet Oncol. 2010, 11:934-41. 10.1016\/S1470-2045(10)70187-X","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar S","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, et al.. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016, 17:e328-46. 10.1016\/S1470-2045(16)30206-6","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/179478-immunoglobulin-e-ige-mediated-multiple-myeloma-presenting-as-pleural-effusion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:52Z","timestamp":1707508492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/179478-immunoglobulin-e-ige-mediated-multiple-myeloma-presenting-as-pleural-effusion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.45802","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,22]]}}}